There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Adynamic bone disease, characterized by a low bone formation rate with normal or reduced
amount of unmineralized osteoid, is supposed to be the consequence of aluminum intoxication
in uremic patients. However, the emergence of adynamic bone disease has been recently
reported in hemodialyzed patients in the total absence of aluminum overload. This
study was aimed to assess whether such a histological pattern of adynamic bone disease
was already present in uremic patients not yet on dialysis. Twenty-seven asymptomatic
uremic patients (mean age +/- SD 43 +/- 10 years, mean creatinine clearance 19 +/-
3 ml/mm) were studied and bone biopsies were repeated in 16 of them after 18 +/- 10
months of treatment with oral calcium carbonate (1-3 g of elemental calcium/day) and
calcidiol (21 +/- 14 micrograms/day). None of the patients received aluminum hydroxide,
and the search for bone aluminum deposits was negative in all patients both before
and after treatment. Two patients fulfilled the criteria of adynamic bone disease
on their post-treatment biopsies. They originated from patients classified as having
normal bone histology before treatment. Comparison with the other patients showed
that they had comparable plasma C-terminal PTH but higher plasma creatinine than patients
with normal bone histology and lower plasma C-terminal PTH than patients with osteitis
fibrosa but comparable plasma creatinine. The plasma levels of 1,25(OH)2D reached
values above normal after treatment in these two patients. It is suggested that adynamic
bone disease not related to aluminum intoxication can develop in uremic patients independently
of dialysis, and is favored by a relative hypoparathyroidism for the degree of renal
failure, possibly induced by elevated plasma concentrations of calcitriol.